|
Volumn 93, Issue 5, 2001, Pages 662-666
|
Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas
|
Author keywords
Angiogenesis; Esophageal carcinoma; Lymph node metastasis; VEGF C
|
Indexed keywords
CD34 ANTIGEN;
GENE PRODUCT;
MESSENGER RNA;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
VASCULOTROPIN C;
VASCULOTROPIN RECEPTOR 3;
ANGIOGENESIS;
ARTICLE;
CANCER INVASION;
CANCER STAGING;
CONTROLLED STUDY;
ESOPHAGUS CARCINOMA;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
LYMPH NODE METASTASIS;
LYMPHATIC SYSTEM;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SQUAMOUS CELL CARCINOMA;
TUMOR VASCULARIZATION;
CARCINOMA, SQUAMOUS CELL;
ENDOTHELIAL GROWTH FACTORS;
ESOPHAGEAL NEOPLASMS;
HUMANS;
IMMUNOHISTOCHEMISTRY;
PROGNOSIS;
RECEPTOR PROTEIN-TYROSINE KINASES;
RECEPTORS, GROWTH FACTOR;
TUMOR CELLS, CULTURED;
VASCULAR ENDOTHELIAL GROWTH FACTOR C;
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;
|
EID: 0035452475
PISSN: 00207136
EISSN: None
Source Type: Journal
DOI: 10.1002/ijc.1379 Document Type: Article |
Times cited : (179)
|
References (23)
|